DMAC DiaMedica Therapeutics Inc.
$8.69▼ -0.57%
Healthcare
Other
After hours
$8.69▲ +0.00%
Oct 27, 4:01 PM ET
Volume 268.7K
Avg Volume (10D) 194.7K
Key Metrics & Fundamentals
Market Cap
$468.61M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.25 - 10.42
% vs 50 MA
16.86%
% vs 200 MA
22.54%
RSI-14
62.4
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.49
Free Cash Flow
-$8.12M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$10.49M
COGS
–
Operating Exp
$10.50M
Operating Income
-$10.50M
EBIT
-$10.50M
Pretax Income
-$10.13M
Net Income
-$10.14M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
DiaMedica Therapeutics Reaches Patient Enrollment Milestone for Phase 2/3 Trial of DM199 in Acute Ischemic Stroke
MT Newswires · Oct 22, 2026 10:11 AM ET
DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
Business Wire · Oct 22, 2026 8:00 AM ET
DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader Webinar
Business Wire · Oct 19, 2026 8:00 AM ET
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
Business Wire · Sep 30, 2026 8:30 AM ET
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
Business Wire · Sep 2, 2026 8:30 AM ET
Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a Bet
Zacks · Aug 26, 2026 9:55 AM ET
DiaMedica (DMAC) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 17, 2026 9:29 PM ET
All You Need to Know About DiaMedica Therapeutics (DMAC) Rating Upgrade to Buy
Zacks · Aug 13, 2026 12:00 PM ET
DiaMedica Therapeutics Inc (DMAC) (Q2 2026) Earnings Call Highlights: Promising Preeclampsia ...
GuruFocus.com · Aug 11, 2026 3:01 PM ET
DiaMedica Therapeutics Inc. Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 1:26 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DMAC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.